Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Journal of Nature and Science|October 18, 2016
ADORA2b Signaling in CardioprotectionJennifer Gile, Tobias EckleCritical Care Medicine|March 1, 2018
The Period 2 Enhancer Nobiletin as Novel Therapy in Murine Models of Circadian Disruption Resembling DeliriumJennifer Gile, Benjamin Scott, Tobias EckleCurrent Pharmaceutical Design|April 16, 2020
A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive DysfunctionJennifer Gile, Yoshimasa Oyama, Sydney Shuff, et al.Current Pharmaceutical Design|July 13, 2017
Circadian MicroRNAs in CardioprotectionYoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.Current Pharmaceutical Design|September 25, 2018
The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion InjuryYoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.Current Pharmaceutical Design|May 18, 2019
Circadian-Hypoxia Link and its Potential for Treatment of Cardiovascular DiseaseColleen Marie Bartman, Tobias EckleNature Medicine|November 9, 2011
Ischemia and reperfusion--from mechanism to translationHolger K Eltzschig, Tobias EckleJournal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 10, 2004
The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assayTobias Eckle, Gerhard Jahn, Klaus HamprechtJournal of Visualized Experiments : Jove|May 5, 2011
Use of a hanging weight system for coronary artery occlusion in miceTobias Eckle, Michael Koeppen, Holger EltzschigCurrent Pharmaceutical Design|February 8, 2014
Anesthetic cardioprotection: the role of adenosineStephanie Bonney, Kelly Hughes, Tobias EcklePageof 8